SAN ANTONIO -- Patients with early breast cancer who skipped axillary lymph node dissection (ALND) lived just as long as those who underwent sentinel lymph node biopsy (SLNB), the randomized INSEMA ...
Please provide your email address to receive an email when new articles are posted on . Certain groups of women with early-stage breast cancer may not benefit from sentinel lymph node biopsy.
Omitting SLNB in older patients with early-stage, HR-positive, HER2-negative breast cancer showed similar safety and efficacy to performing the procedure. The BOOG 13-08 trial demonstrated comparable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results